Trending
How to Read a Peptide COA: HPLC, Mass Spec and Lot Checks
2026-11-02 · 3 min read
A peptide certificate of analysis, or COA, should help a laboratory evaluate a specific lot—not simply display an impressive purity percentage. Reading it correctly means separating identity, chromatographic purity, and peptide content, then checking whether the supporting results match the material being purchased. This guide explains what HPLC and mass spectrometry can establish, where their limitations matter, and how to review lot-specific documentation before ordering research peptide kits.
1. Start With the Lot Number and Testing Scope
Begin with traceability. Look for the compound name or code, sample identifier, lot or batch number, testing laboratory, report date, and analytical methods. The lot on the COA should match the lot supplied. A report for a different batch may illustrate a supplier’s testing approach, but it does not establish the characteristics of the material in your shipment.
Distinguish a supplier-issued summary from the underlying laboratory report. If third-party testing is claimed, check who performed it and whether the report can be authenticated through the laboratory’s available verification process. Also ask what was sampled: bulk material, a finished vial, or a representative sample from a filling run. Those distinctions affect how confidently results can be applied to the purchased kit.
2. Read HPLC Purity as a Method-Dependent Result
High-performance liquid chromatography, or HPLC, separates components under defined analytical conditions. A reported purity percentage often represents the main peak’s integrated area relative to the total integrated peak area. To interpret it, review the chromatogram, peak table, detection wavelength, and available method details—not just the percentage printed on the first page.
Area-percent purity is not automatically the percentage of peptide by weight. Water, counterions, residual solvents, and substances poorly detected by the method may not be reflected adequately. Different compounds can also produce different detector responses, and impurities can co-elute with the main peak. A high HPLC result therefore does not independently establish peptide content, sterility, or suitability for a particular experiment.
3. Use Mass Spectrometry to Evaluate Identity
Mass spectrometry measures mass-to-charge ratios. For peptide identity assessment, the observed signals should be consistent with the expected compound, including relevant modifications and the reported ion forms. Peptides can produce multiple charge states, so the displayed mass-to-charge value may differ from the peptide’s neutral molecular mass without indicating a problem.
Check whether the report provides expected and observed values, identifies the measurement convention, and includes supporting spectra or an interpretation. A mass match supports identity, but it does not necessarily establish the complete sequence or distinguish every isomeric impurity. HPLC and mass spectrometry provide complementary evidence; neither should be treated as a universal substitute for the other.
4. Identify What the COA Does Not Establish
Purity, identity, and quantity answer different questions. A vial’s labeled amount should not be inferred from an HPLC area percentage or a mass-confirmation result. If experimental reproducibility depends on peptide quantity, request an appropriate quantitative assay and clarify whether the reported amount refers to net peptide, peptide salt, or total material. Reference standards, calibration, and the assay basis matter.
Other attributes require their own evidence. Endotoxin, microbial contamination, sterility, residual solvents, water content, and elemental impurities are not automatically covered by a basic HPLC and mass spectrometry report. Select additional testing according to the research application and institutional requirements. If an attribute is not reported, treat it as unverified rather than assuming that a high purity value covers it.
5. Apply COA Review to Wholesale Kit Purchasing
Before ordering, request the COA for the lot expected to ship and confirm how substitutions are handled. On receipt, reconcile vial labels and shipping documentation with the report, preserve the records, and follow a documented incoming-material review process. A single COA does not establish that every vial was individually tested or that fill uniformity was assessed; ask about sampling and filling controls when those details matter.
Wholesale American Peptides supplies research peptides in 10-vial kits with a one-kit minimum and a third-party COA per lot. Shipping is $19.99 for 1–2 kits, $24.99 for 3–4 kits, and free for 5 or more kits. Volume discounts are 5% at 2 kits, 7% at 3 kits, 12% at 5 kits, and 20% at 10 kits. Compare purchasing costs only after confirming that the documentation meets your laboratory’s needs. All compounds are for research use only, not for human or animal administration.
Frequently asked
- Does 99% HPLC purity mean a vial contains 99% peptide by weight?
- Not necessarily. HPLC purity commonly describes the main peak’s share of integrated chromatographic area under a particular method. It does not independently measure peptide content by weight or account for every component in the vial.
- Does a matching mass spectrum prove the complete peptide sequence?
- A matching molecular mass supports identity but does not necessarily prove the full sequence or distinguish compounds with the same mass. Sequence-sensitive analysis or other complementary methods may be needed for a specific research objective.
- Why does a lot-specific COA matter?
- Analytical results apply to the sample tested. Matching the COA to the supplied lot provides traceability and helps laboratories assess whether the documentation is relevant to their material. It does not mean every vial was tested individually.
- Does a third-party COA make a research peptide suitable for administration?
- No. A third-party report documents only the analyses performed on the submitted sample. It does not establish clinical suitability, regulatory approval, or authorization for administration. Wholesale American Peptides products are for research use only.